相关实验视频

Updated: Jan 16, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

在分子分层子宫内膜癌中进行术前复发预测的可解释的机器学习:单中心芬兰队列研究

Sergio Vela Moreno^1,2, Masuma Khatun^1,3,4, Annukka Pasanen⁴

¹Department of Obstetrics and Gynecology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.

Computational and structural biotechnology journal

|January 15, 2026

概括

机器学习模型使用手术前数据预测子宫内膜癌复发风险. 这使得早期的个性化风险分层成为可能,特别是在高风险的分子亚型中,改善了患者管理.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
机器学习机器学习

背景情况:

子宫内膜癌 (EC) 复发风险与分子亚型有关.
目前的分类使用术后数据,阻碍了术前风险评估.
准确的手术前分层对于及时干预至关重要.

研究的目的:

开发可解释的机器学习 (ML) 模型来预测EC复发时间.
仅使用手术前的多式联络数据来开发模型.
能够实现个性化的手术前风险分层.

主要方法:

784名欧洲共同体患者的手术前数据的回顾性分析.
临床病理学,分子,免疫组织化学和系统生物标志物的整合.
训练和评估随机森林和梯度增强模型使用SHAP进行解释性.

主要成果:

随机森林-传统模型显示了强大的整体性能 (F1=0.895,AUC=0.840).
渐变增强-POLE模型实现了高灵敏度 (F1=0.886,AUC=0.842).
由于数据稀有性和异质性,预测晚期复发是具有挑战性的.

结论:

可解释的ML模型可以使用手术前数据预测EC复发风险.
这些发现支持生物学上连贯的,个性化的术前风险分层.
进一步的多中心验证对于临床实施是必要的.

关键词:

这是子宫内膜癌的癌症.可解释的人工智能 (XAI)机器学习机器学习分子分类的分子分类.在手术前预测预测.复发的时间是什么?风险分层是指风险的分层.这就是 SHAP SHAP 的意思.

更多相关视频

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...